Moderna has a host of vaccines in its pipeline, including against cancer and HIV. It's not a one-trick pony. More
Articles
Fisker Stock Could Be a Long-Term Buy, But Wait Until You See the Ocean
Investors will have to wait another year before Fisker's first vehicle, the Ocean, goes into production. However, a sneak preview may give FSR stock a lift. More
Novavax Stock Looks Interesting as the World Still Needs Vaccines
There are plenty of reasons to stay invested in NVAX stock as the Delta variant forces a renewal of fortunes for the vaccine also-ran. More
Meta Materials Stock Is a Speculative Play That Could Pay Off Big
Speculators are betting that Meta has promising nanocomposites that address multiple markets, realizing revenue in 1H/2022. More
This One Chart Shows Why Bitcoin Could Soar to $100,000
We’re sitting at multi-year high levels in the Bitcoin LTH Supply Shock Ratio. And history says what comes next is a big move higher in Bitcoin prices over the next few months. More
Debt, Rivals Leave SmileDirectClub Investors With Little to Smile About
Along with soaring competitive pressures and SmileDirectClub's fragile balance sheet, long-term prospects remain volatile for SDC stock. More
